Advertisement.

MACK Projected Dividend Yield

Merrimack Pharmaceuticals Inc ( NASDAQ : MACK )

Merrimack Pharmaceuticals is a biopharmaceutical company. Co. does not have any ongoing research or development activities.

15 YEAR PERFORMANCE RESULTS

MACK Dividend History Detail
MACK Dividend News
MACK Competitors News

# of Shares: 0

Closing Price: 14.72

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.50	0%	0	$ 0.00	3.40%
2025	0.00	0%	0	$ 0.00	3.40%
2026	0.00	0%	0	$ 0.00	3.40%
2027	0.00	0%	0	$ 0.00	3.40%
2028	0.00	0%	0	$ 0.00	3.40%
2029	0.00	0%	0	$ 0.00	3.40%
2030	0.00	0%	0	$ 0.00	3.40%
2031	0.00	0%	0	$ 0.00	3.40%
2032	0.00	0%	0	$ 0.00	3.40%
2033	0.00	0%	0	$ 0.00	3.40%
2034	0.00	0%	0	$ 0.00	3.40%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 3.40%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00